Rasha Aboelhassan: Choosing the Right Anti Cancer Molecules for the Right Patient is a Big Challenge

Rasha Aboelhassan, Senior Oncology Consultant at Nasser Institute Hospital, Egypt, shared a post on LinkedIn:

“Choosing the right anti cancer molecules for the right patient profile is a big challenge, except if we have well-balanced MDT, which can dive deep into the details of results of randomized clinical trials, real world data as well as patients references.

This was the main conclusion of my talk during yesterday’s meeting with young oncologists.

Although it was very late, 11 pm but they were really excited and responded to my question during the discussion .

On the other hand, I left the room after end of the meeting exhausted but optimistic
young oncologists made my day.

Thanks for the sponsors Mostafa Darwish and all members.

Thanks for your Prof Hesham Abbas.”

More posts featuring Rasha Aboelhassan on OncoDaily.